Diversify Advisory Services LLC Invests $8.98 Million in HealthEquity, Inc. $HQY

Diversify Advisory Services LLC bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 90,675 shares of the company’s stock, valued at approximately $8,981,000. Diversify Advisory Services LLC owned about 0.11% of HealthEquity at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in HQY. Acumen Wealth Advisors LLC bought a new stake in HealthEquity during the 4th quarter worth about $27,000. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity during the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd grew its holdings in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares in the last quarter. Leonteq Securities AG grew its holdings in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC acquired a new stake in shares of HealthEquity in the first quarter valued at about $33,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

NASDAQ:HQY opened at $102.79 on Wednesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62. The firm has a market capitalization of $8.59 billion, a price-to-earnings ratio of 38.50, a P/E/G ratio of 1.76 and a beta of 0.21. The stock’s 50 day moving average price is $95.71 and its two-hundred day moving average price is $86.80. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 over the last ninety days. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on HQY shares. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Wells Fargo & Company set a $111.00 price target on HealthEquity in a research report on Monday, June 1st. BTIG Research upped their price objective on HealthEquity from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Royal Bank Of Canada upped their price objective on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Finally, Citizens Jmp increased their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.